Effects of retinoic acid combined with interferon-gamma on the expression of major-histocompatibility-complex molecules and intercellular adhesion molecule-1 in human cervical cancer

International Journal of Cancer

Volumn 75, Issue 2, 1998, Pages 254-258

  Santin, Alessandro D ^a,c,d   Hermonat, Paul ^a   Ravaggi, Antonella ^a,c   Chiriva Internati, Maurizio ^a,c   Hiserodt, John C ^b   Tian, Erming ^a   Carter, Charleata A ^a   Pecorelli, Sergio ^c   Parham, Groesbeck P ^a  

^a UNIVERSITY OF ARKANSAS AT LITTLE ROCK   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF BRESCIA   (Italy)

^d UNIVERSITY OF ARKANSAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; RETINOIC ACID;

ANTIGEN EXPRESSION; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; NORTHERN BLOTTING; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA; WART VIRUS;

BLOTTING, NORTHERN; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERFERON TYPE II; TRETINOIN; TUMOR CELLS, CULTURED; UTERINE CERVICAL NEOPLASMS;

EID: 0032545644     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980119)75:2<254::AID-IJC14>3.0.CO;2-D     Document Type: Article

References (22)

1. AGARWAL, C. HEMBREE, J.R., RORKE, E.A. and ECKERT, R.A., Interferon and retinoic acid suppress the growth of human-papillomavirus-type-16-immortalized cervical epithelial cells. but only interferon suppresses the level of the human papillomavirus transforming oncogenes. Cancer Res., 54, 2108-2112 (1994).
2. ALEXANDER, M., SALGALLER, M.L., CELIS, E., SETTE, A., BARNES, W.A., ROSENBERG, S.A. and STELLER, M.A., Generation of tumor-specific cytolytic T lymphocytes from peripheral blood of cervical-cancer patients by in vitro stimulation with a synthetic human-papillomavirus-type-16-E7 epitope. Amer. J. Obstet. Gynecol., 175, 1586-1593 (1996).
3. BRINTON. L.A., Epidemiology of cervical cancer: Overview. In: N. Munoz, F. Bosh, K.V. Shah, and A. Meheus (eds.), The epidemiology of human papillomavirus and cervical cancer, IARC Scientific Publication 119, pp. 3-23, IARC, Lyon (1992).
4. CHEN, L., THOMAS, E.K., HU, S.-L., HELLSTRÖM, I. and HELLSTRÖM, K.E., Human-papilloma-virus-type-16 nucleoprotein E7 is a tumor-rejection antigen. Proc. nat. Acad. Sci. (Wash.), 88, 110-114 (1991).
5. DE MAEYER, E. and DE MAEYER-GUIGNARD, L., Interferons. In: A.W. Thomson (ed.), The cytokine handbook, pp. 216-239, Academic Press, New York (1991).
6. DISAIA, P.J. and CREASMAN, W.T., Pre-invasive disease of the cervix. In: P.J. DiSaia and W.T Creasman (eds.), Clinical gynecologic oncology, pp. 1-36, Mosby-Year Book, St. Louis (1993).
7. DOZMOROV, I.M., LEE, S.Y. and PARK, K.-C., Effects of retinoids on regulatory cellular interactions in primary mixed-lymphocyte reaction (MLC). Immnopharmacol. Immunotoxicol., 17, 665-685 (1995).
8. GARDNER, F.J.E. and WALKER, R.A., Modulation of cell-surface components of human breast-cancer cells by retinoic acid: enhanced HLA-DR expression. J. Pathol., 170, 23-29 (1993).
9. JANG, X.L., DILLEHAY, D.L., EVERSON, M.P., TILDEN, A.B. and LAMON, E.W., Potentiation of IL-2-induced T-cell proliferation by retinoids. Int. J. Immunopharmacol., 14, 195-204 (1992).
10. LIPPMAN, S.M., KAVANAGH, J.J., PAREDES-ESPINOZA, M., DEGALDILLO-MADRUFNO, F., PAREDES-CASILLAS, P., KI HONG, W., HOLDENER, E. and KRAKOFF, I.H., 13-cis-retinoid acid plus interferon α-2a: highly active systemic therapy for squamous-cell carcinoma of the cervix. J. nat. Cancer Inst., 84, 241-245 (1992).
11. MANIATIS, T., FRITSCH, E.F. and SAMBROOK, J., Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory, New York (1982).
12. MCFADDEN, G. and KANE, K., How DNA viruses perturb functional MHC expression to alter immune recognition. Advance. Cancer Res.,63, 117-209 (1994).
13. MEUNIER, L., BOHJANEN, K., VOORHEES, J.J. and COOPER, K.D., Retinoic acid up-regulates human Langerhans-cell-antigen presentation and surface expression of HLA-DR and CD11c, a β2 integrin critically involved in T-cell activation. J. invest. Dermatol., 103, 775-779 (1994).
14. MEYSKENS, F.L., GRAHAM, V., CHVAPIL, M. DORR, R.T., ALBERTS, D.S. and SURWIT, E.S., A phase-I trial of β-all-trans retinoid acid delivered via a collagen sponge and cervical cap for mild and moderate intra-epithelial cervical neoplesia. J. nat. Cancer Inst., 71, 921-925 (1983).
15. NICKOLOFF, B.J., BASHAM, T.Y., MERIGAN, T.C. and MORHENN, V.B., Anti-proliferative effects of recombinant and γ interferons on cultured human keratinocytes. Lab. Invest., 51, 697-701 (1984).
16. OKADA, Y., YAHATA, G., TAKEUCHI, S., SEIDOH, T. and TANAKA, K., A correlation between the expression of CD8 antigen and specific cytotoxicity of tumor-infiltrating lymphocytes. Jap. J. Cancer Res., 80, 249-256 (1989).
17. PENN, I., Cancers of the anogenital region in renal-transplant recipients. Analysis of 65 cases. Cancer, 58, 611-616 (1988).
18. RELLIHAN, M.A., DOOLEY, D.P., BURKE, T.W., BERKLAND, M.E. and LONGFIELD, R.N., Rapidly progressing cervical cancer in a patient with humun-immunodeficiency-virus infection. Gynecol. Oncol., 36, 435-438 (1990).
19. RUBIN, B.Y, and GUPTA, S.L., Differential efficacies of human type-I and type-II interferons as anti-viral and anti-proliferative agents. Proc. nat. Acad. Sci. (Wash.), 77, 5928-5935 (1980).
20. SPORN, M.B. and ROBERTS, A.B., Role of retinoids in differentiation and carcinogenesis. Cancer Res., 43, 3034-3040 (1983).
21. VAN DRIEL, W., TJIONG, M.Y., HILDFRS, C.G.J.M., TRIMBOS, B.J. and FLEUREN, G.J., Association of allele-specific HLA expression and histopathologic progression of cervical carcinoma. Gynecol. Oncol., 62, 33-41 (1996).
22. VANKY, F., WANG, P., PATARROYO, M. and KLEIN, E., Expression of the adhesion molecule ICAM-1 and the major-histocompatibility-complex antigens on human tumor cells is required for their interaction with autologous lymphocytes in vitro. Cancer Immunol. Immunother., 31, 19-27 (1990).